Cerity Partners LLC Adma Biologics, Inc. Transaction History
Cerity Partners LLC
- $45.5 Billion
- Q4 2024
A detailed history of Cerity Partners LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 43,128 shares of ADMA stock, worth $888,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,128
Previous 50,878
15.23%
Holding current value
$888,868
Previous $1.02 Million
27.34%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$384 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$375 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$306 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$233 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$114 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.05B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...